• CFDA SE Cell Tracer Kit: Technical Guide for Reliable Cell T

  2026-06-19

  The CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Cell Tracer Kit is designed for stable, long-term fluorescent labeling in cell proliferation and lineage tracing workflows. It is best suited for both in vitro and in vivo experiments that require persistent, minimally cytotoxic staining. This kit should not be used for reversible or short-term cell labeling applications.

• Trelagliptin Succinate Promotes Osteoblast Differentiation v

  2026-06-18

  The referenced study provides mechanistic evidence that Trelagliptin succinate, a DPP-4 inhibitor primarily used in type 2 diabetes research, can stimulate osteoblastic differentiation and mineralization through the AMPK–RUNX2 pathway. These findings open new avenues for exploring SYR-472 succinate in osteoporosis and bone metabolism models.

• KU-55933: ATM Kinase Inhibitor for DNA Damage Response Resea

  2026-06-18

  KU-55933 empowers researchers to dissect the DNA damage response with nanomolar precision, enabling advanced studies in cell cycle regulation and cancer biology. Its selectivity and robust workflow versatility make it the gold-standard ATM kinase inhibitor for high-fidelity DNA damage assays.

• Applied Use-Cases of Salvianolic Acid B in Fibrosis Research

  2026-06-17

  Salvianolic acid B (Dan Shen Suan B) enables targeted inhibition of LH2, offering researchers a high-precision tool for dissecting collagen cross-linking in fibrotic disease models. This article unpacks experimental workflows, troubleshooting strategies, and unique advantages of this natural antifibrotic agent, with practical guidance for maximizing reproducibility in pulmonary fibrosis studies.

• Isoprinosine (Inosine Pranobex): Immunotherapy Workflow Guid

  2026-06-17

  Isoprinosine (inosine pranobex) unlocks robust viral inhibition and immune enhancement for acute respiratory and herpesvirus research. This guide delivers stepwise protocols, troubleshooting, and the latest reference-backed insights—empowering seamless integration of Isoprinosine into antiviral and immunotherapy workflows.

• X-press Tag Peptide: Precision Tools for Translational mTORC

  2026-06-16

  Explore how the X-press Tag Peptide, a high-purity N-terminal leader peptide, is transforming protein purification and detection workflows in the context of translational cancer research. By integrating mechanistic insights from recent discoveries on RHEB neddylation and mTORC1 signaling, this article offers strategic, evidence-based guidance for researchers aiming to accelerate reproducible, high-impact studies in hepatocellular carcinoma and beyond.

• Berberine Hydrochloride: Mechanisms, Evidence, and Research

  2026-06-16

  Berberine hydrochloride is a bioactive alkaloid with demonstrated gut-bone axis and metabolic regulatory effects. Its ability to modulate intestinal tuft cells, activate AMPK, and inhibit inflammatory bone loss is underpinned by robust, recent research. This profile details its mechanisms, experimental benchmarks, and workflow integration for translational studies.

• Deciphering Hepatic Uptake of PEGylated Iron Oxide Nanoparti

  2026-06-15

  This study systematically investigates how PEG chain length and nanoparticle size dictate the cellular uptake and hepatic distribution of iron oxide nanoparticles, revealing an unexpected dominance of hepatocyte and hepatic stellate cell uptake over Kupffer cells. These findings redefine design principles in nanomedicine delivery and suggest practical avenues for optimizing nanoparticle-based diagnostics and therapeutics.

• Cardioprotective Mechanisms of Olive Oil Polyphenols Explain

  2026-06-15

  Boumezough et al. (2025) systematically dissect how extra virgin olive oil (EVOO) polyphenols—especially hydroxytyrosol—exert antioxidant, anti-inflammatory, and anti-atherogenic effects relevant to cardiovascular research. Their work highlights the importance of polyphenol concentration, providing a mechanistic foundation for dose-dependent efficacy in cellular models.

• Olsalazine Sodium: Molecular Innovations in Xenobiotic Trans

  2026-06-14

  Explore how Olsalazine Sodium, a potent mesalamine dimer, advances molecular xenobiotic transport research and colorectal cancer models. This article reveals novel insights into transporter biology and anti-inflammatory mechanisms, setting a new standard for scientific rigor.

• Canagliflozin Hemihydrate: Applied Workflows for Glucose Res

  2026-06-13

  Canagliflozin hemihydrate delivers precision and reproducibility for glucose metabolism and diabetes mellitus research. This guide distills hands-on protocols, advanced workflow strategies, and evidence-driven troubleshooting to empower metabolic disorder studies beyond traditional SGLT2 inhibitors.

• Berberine Hydrochloride: Protocols & Innovations for Metabol

  2026-06-12

  Berberine hydrochloride unlocks mechanistic and translational advantages in metabolic, cancer, and cardiovascular disease research. This guide details best-practice workflows, troubleshooting strategies, and actionable protocol parameters that maximize reproducibility and scientific impact.

• Anagliptin (SK-0403): Mechanistic Insights for Vascular Phar

  2026-06-12

  Explore the unique DPP-4 inhibition and vasorelaxant mechanisms of Anagliptin (SK-0403), with a deep dive into its Kv channel and SERCA pump modulation. This article offers advanced, evidence-driven perspectives for diabetes and vascular research.

• 2-Deoxy-D-glucose in Cancer Metabolism: Beyond Glycolysis In

  2026-06-11

  Explore the multifaceted role of 2-Deoxy-D-glucose (2-DG) in cancer metabolism and metabolic stress induction. This article provides advanced insights into glycolysis inhibition and the molecular interplay with cellular senescence, offering a unique perspective for oncology researchers.

• Disulfiram: Dopamine β-Hydroxylase Inhibitor & Cancer Resear

  2026-06-11

  Disulfiram is a clinically established dopamine β-hydroxylase inhibitor and copper-binding agent that induces apoptotic cancer cell death by inhibiting proteasomal chymotrypsin-like activity. Extensive evidence supports its use in breast cancer MDA-MB-231 cell research, with robust in vitro and in vivo efficacy benchmarks. This article details the molecular rationale, workflow integration, and current limitations for translational and mechanistic studies.

14826 records 1/989 page Next 12345 下5页 Last page